DoctorsProofNPPES directory · verify at state boards

Pulmonary Disease in Metairie, LA

8 verified pulmonary disease doctors in Metairie.

Pulmonologists diagnose and treat diseases of the lungs and respiratory system, such as asthma, COPD, and sleep apnea.

NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.

Verify a license at the Louisiana State Board of Medical Examiners

Dr. James Mccullough, MD

Pulmonary Disease

21 yrs NPPES
NPI 1104803766
4228 HOUMA BLVD STE 140, Metairie, LA 70006(504) 455-2333
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,306 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,306

Total received

65

Transactions

12

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$310.72
GlaxoSmithKline, LLC.$308.01
Regeneron Healthcare Solutions, Inc.$141.67
Boehringer Ingelheim Pharmaceuticals, Inc.$122.58
Genzyme Corporation$117.82
Actelion Pharmaceuticals US, Inc.$88.47

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 82th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to James Mccullough do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Henry Jackson, MD

Pulmonary Disease

20 yrs NPPES
NPI 1679549836
4224 HOUMA BLVD STE 380, Metairie, LA 70006(504) 454-5213
NPPES public registry
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Thomas Nuttli, MD

Pulmonary Disease

20 yrs NPPES
NPI 1356310783
4200 HOUMA BLVD, FL 3, Metairie, LA 70006(504) 503-5205
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,839 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,839

Total received

96

Transactions

17

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$526.28
GlaxoSmithKline, LLC.$373.13
Boehringer Ingelheim Pharmaceuticals, Inc.$201.48
Mylan Specialty L.P.$146.14
Actelion Pharmaceuticals US, Inc.$118.40
Genzyme Corporation$112.69

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 85th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Thomas Nuttli do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Kenneth Smith, MD

Pulmonary Disease

20 yrs NPPES
NPI 1356310650
4200 HOUMA BLVD FL 3, Metairie, LA 70006(504) 503-5205
NPPES public registry
CMS Open Payments· $546.21 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$546.21

Total received

27

Transactions

13

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$76.99
Mylan Specialty L.P.$72.63
Regeneron Healthcare Solutions, Inc.$65.27
Genzyme Corporation$47.23
AstraZeneca Pharmaceuticals LP$40.75
Grifols USA, LLC$40.49

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 74th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Kenneth Smith do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Eugene Rosenberg, MD

Pulmonary Disease

20 yrs NPPES
NPI 1841228624
3609 N ARNOULT RD, Metairie, LA 70002(772) 342-4605
NPPES public registry
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Enrique Diaz Guzman Zavala, MD

Pulmonary Disease

19 yrs NPPES
NPI 1326229733
4200 HOUMA BLVD, Metairie, LA 70006(504) 988-3541
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $402.03 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$402.03

Total received

21

Transactions

12

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$81.62
AstraZeneca Pharmaceuticals LP$56.34
Amgen Inc.$48.01
Mylan Specialty L.P.$38.13
Getinge USA Sales, LLC$29.63
Actelion Pharmaceuticals US, Inc.$25.10

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 71th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Enrique Diaz Guzman Zavala do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Clayton Eiswirth, MD

Pulmonary Disease

17 yrs NPPES
NPI 1639307861
4430 VETERANS MEMORIAL BLVD, Metairie, LA 70006(504) 842-4055
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,218 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,218

Total received

66

Transactions

17

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$291.70
AstraZeneca Pharmaceuticals LP$245.03
Actelion Pharmaceuticals US, Inc.$109.54
Mylan Specialty L.P.$79.85
Genzyme Corporation$71.42
Boehringer Ingelheim Pharmaceuticals, Inc.$65.83

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 81th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Clayton Eiswirth do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Brooks Culotta, MD

Pulmonary Disease

9 yrs NPPES
NPI 1063944494
4224 HOUMA BLVD STE 140, Metairie, LA 70006(504) 503-6565
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $410.97 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$410.97

Total received

13

Transactions

8

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$175.35
Regeneron Healthcare Solutions, Inc.$90.89
Boehringer Ingelheim Pharmaceuticals, Inc.$43.13
ABIOMED$23.00
United Therapeutics Corporation$22.29
Genzyme Corporation$22.08

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 72th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Brooks Culotta do not imply any wrongdoing. Many are meals, education, or research support.

Pulmonary Disease in Metairie, LA — Verified | DoctorsProof | DoctorsProof